Stay updated on AK104 with Chemo for Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the AK104 with Chemo for Lung Cancer Clinical Trial page.

Latest updates to the AK104 with Chemo for Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision history shows a new revision label v3.3.2 replacing the previous v3.2.0 on the page, indicating a minor UI/metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the banner about a lapse in government funding and potential data delays, including the instruction to check opm.gov for operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check42 days agoChange DetectedVersion 2 on 2024-02-19 updated several sections of the study record, including recruitment status, study status, description, design, arms/interventions, outcome measures, and contacts/locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference13%

- Check78 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%

- Check93 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element; no substantive changes to core content, pricing, stock, or time-slot availability.SummaryDifference0.8%

Stay in the know with updates to AK104 with Chemo for Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 with Chemo for Lung Cancer Clinical Trial page.